B-cell lymphoma proteins 3D structures - Revision history

Michal Harel at 07:26, 27 October 2022

Michal Harel — Thu, 27 Oct 2022 07:26:14 GMT

←Older revision		Revision as of 07:26, 27 October 2022
Line 14:		Line 14:
	**[[2mej]] - hBcl-xL + p53 - NMR<br />		**[[2mej]] - hBcl-xL + p53 - NMR<br />
	**[[6lhd]] - hBcl-xL/p53 <br />		**[[6lhd]] - hBcl-xL/p53 <br />
-	**[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]], [[6rnu]], [[6vwc]], [[7jgv]], [[7jgw]] - hBcl-xL + inhibitor<br />	+	**[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]], [[6rnu]], [[6vwc]], [[7jgv]], [[7jgw]], [[7lh7]] - hBcl-xL + inhibitor<br />
		+	**[[7xgf]] - hBcl-xL + inhibitor protein<br />
	**[[3inq]] - hBcl-xL (mutant) + inhibitor<br />		**[[3inq]] - hBcl-xL (mutant) + inhibitor<br />
	**[[2w3l]] – hBcl-xL + quinoline derivative<br />		**[[2w3l]] – hBcl-xL + quinoline derivative<br />
Line 41:		Line 42:
	**[[5b1z]] - hBcl-xL + BHX BH3 domain<br />		**[[5b1z]] - hBcl-xL + BHX BH3 domain<br />
	**[[4z9v]] - hBcl-xL + TCTP BH3 domain<br />		**[[4z9v]] - hBcl-xL + TCTP BH3 domain<br />
		+	**[[7wjh]] - hBcl-xL + Pxt1 BH3 domain<br />
	**[[6dcn]], [[6dco]] - hBcl-xL + Beclin-1 BH3 domain<br />		**[[6dcn]], [[6dco]] - hBcl-xL + Beclin-1 BH3 domain<br />
	**[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain<br />		**[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain<br />
Line 59:		Line 61:
	**[[4aq3]], [[4man]], [[5jsn]], [[4ieh]], [[6gl8]], [[6qgg]], [[6qgj]], [[6qgk]], [[7jmt]] – hBcl-2 + inhibitor<br />		**[[4aq3]], [[4man]], [[5jsn]], [[4ieh]], [[6gl8]], [[6qgg]], [[6qgj]], [[6qgk]], [[7jmt]] – hBcl-2 + inhibitor<br />
	**[[4lvt]], [[4lxd]], [[6o0k]], [[6o0m]], [[6o0o]], [[6o0p]] – hBcl-2 (mutant) + inhibitor<br />		**[[4lvt]], [[4lxd]], [[6o0k]], [[6o0m]], [[6o0o]], [[6o0p]] – hBcl-2 (mutant) + inhibitor<br />
-	**[[7lhb]] – hBcl-2 + drug<br />	+	**[[7lhb]] – hBcl-2 (mutant) + drug<br />
	**[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br />		**[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain<br />
	**[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br />		**[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain<br />
Line 139:		Line 141:
	**[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br />		**[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant)<br />
	**[[4u2v]] – hBak/GFP<br />		**[[4u2v]] – hBak/GFP<br />
		+	**[[7ofm]], [[7ofo]] – hBak transmembrane helix - NMR<br />
	**[[3qbr]] - hBak + sjA<br />		**[[3qbr]] - hBak + sjA<br />
	**[[6uxm]], [[6uxn]], [[6uxo]], [[6uxp]], [[6uxq]], [[6uxr]] - hBak + inhibitor<br />		**[[6uxm]], [[6uxn]], [[6uxo]], [[6uxp]], [[6uxq]], [[6uxr]] - hBak + inhibitor<br />
Line 145:		Line 148:
	**[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br />		**[[5vwv]] - hBak (mutant)+ BIM BH3 domain<br />
	**[[2m5b]] - hBak + BID BH3 domain - NMR<br />		**[[2m5b]] - hBak + BID BH3 domain - NMR<br />
		+	**[[7m5c]] – hBak + Bak BH3 peptide<br />
		+	**[[7m5a]], [[7m5b]] – hBak + M3W5 BID<br />
		+	**[[7lk4]] – hBak (mutant) + antibody<br />
	**[[6mcy]] – mBak<br />		**[[6mcy]] – mBak<br />

Line 157:		Line 163:
	**[[2nl9]] – hBim + Mcl-1<br />		**[[2nl9]] – hBim + Mcl-1<br />
	**[[6x8o]] – hBim BH3 peptide<br />		**[[6x8o]] – hBim BH3 peptide<br />
		+
		+	*Bcl-2-like protein 15
		+
		+	**[[7ccl]], [[7ccm]] - hBcl-2-L-15<br />

	Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1)		Mcl-1 (Bcl-2-like protein 3 or Myeloid cell leukemia-1)
Line 167:		Line 177:
	**[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br />		**[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand<br />
	**[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br />		**[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam<br />
-	**[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]], [[6ne5]], [[6o4u]], [[6o6f]], [[6oqb]], [[6oqc]], [[6oqd]], [[6oqn]], [[6p3p]], [[6qgd]], [[6qfq]], [[6qyp]], [[6qz5]], [[6qz6]], [[6qz8]], [[6qzb]], [[6u63]], [[6u64]], [[6u65]], [[6u67]], [[6u6f]], [[6ud2]], [[6udi]], [[6udt]], [[6udu]], [[6udv]], [[6udx]], [[6udy]], [[6ybg]] - hMcl-1 residues 174-324 + inhibitor<br />	+	**[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]], [[6ne5]], [[6o4u]], [[6o6f]], [[6oqb]], [[6oqc]], [[6oqd]], [[6oqn]], [[6p3p]], [[6qgd]], [[6qfq]], [[6qyp]], [[6qz5]], [[6qz6]], [[6qz8]], [[6qzb]], [[6u63]], [[6u64]], [[6u65]], [[6u67]], [[6u6f]], [[6ud2]], [[6udi]], [[6udt]], [[6udu]], [[6udv]], [[6udx]], [[6udy]], [[6ybg]], [[7nb4]], [[7nb7]] - hMcl-1 residues 174-324 + inhibitor<br />
		+	**[[7xge]], [[7xgg]] - hMcl-1 residues 174-324 + protein inhibitor<br />
	**[[6ovc]] - hMcl-1 residues 174-324 + inhibitor - NMR<br />		**[[6ovc]] - hMcl-1 residues 174-324 + inhibitor - NMR<br />
	**[[6qxj]], [[6qyk]], [[6qyl]], [[6qyn]], [[6qyo]], [[6qz7]], [[6ybj]], [[6ybk]], [[6ybl]] - hMcl-1 residues 174-324/MBP + inhibitor<br />		**[[6qxj]], [[6qyk]], [[6qyl]], [[6qyn]], [[6qyo]], [[6qz7]], [[6ybj]], [[6ybk]], [[6ybl]] - hMcl-1 residues 174-324/MBP + inhibitor<br />
Line 196:		Line 207:

	**[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br />		**[[2o42]], [[2jbx]] – MvM11L – Myxoma virus<br />
-	**[[2jby]] – MvM11L + ~~Bcl-2 homologous antagonist/killer~~ <br />	+	**[[2jby]] – MvM11L + Bak <br />
	**[[3dvu]], [[3bl2]], [[4mi8]] – M11 + Beclin-1 – Murid herpesvirus<br />		**[[3dvu]], [[3bl2]], [[4mi8]] – M11 + Beclin-1 – Murid herpesvirus<br />

Michal Harel at 09:29, 4 May 2021

Michal Harel — Tue, 04 May 2021 09:29:10 GMT

←Older revision		Revision as of 09:29, 4 May 2021
Line 74:		Line 74:
	**[[2voh]] - mBcl-2A1 + Bak BH3 peptide <br />		**[[2voh]] - mBcl-2A1 + Bak BH3 peptide <br />
	**[[2voi]] - mBcl-2A1 + BID BH3 peptide <br />		**[[2voi]] - mBcl-2A1 + BID BH3 peptide <br />
-

	*Bcl-3		*Bcl-3
Line 127:		Line 126:
	**[[2k7w]] – hBax + BIM BH3 peptide - NMR<br />		**[[2k7w]] – hBax + BIM BH3 peptide - NMR<br />
	**[[4zie]], [[4zif]], [[4zig]], [[4zih]], [[4zii]], [[5vww]] – hBax (mutant) + BIM BH3 peptide<br />		**[[4zie]], [[4zif]], [[4zig]], [[4zih]], [[4zii]], [[5vww]] – hBax (mutant) + BIM BH3 peptide<br />
		+	**[[6wgz]] – hBax + MBP + Bak BH3 peptide<br />
	**[[4bd2]] – hBax (mutant) + BID BH3 peptide<br />		**[[4bd2]] – hBax (mutant) + BID BH3 peptide<br />
	**[[5w5z]], [[5w5x]] – hBax (mutant) + antibody<br />		**[[5w5z]], [[5w5x]] – hBax (mutant) + antibody<br />

Michal Harel at 08:20, 2 May 2021

Michal Harel — Sun, 02 May 2021 08:20:32 GMT

(Difference between revisions)

Michal Harel at 07:00, 16 June 2020

Michal Harel — Tue, 16 Jun 2020 07:00:48 GMT

←Older revision		Revision as of 07:00, 16 June 2020
Line 81:		Line 81:
	**[[5h7g]], [[5h7h]] – hBcl-6 BTB domain + F1324 peptide<br />		**[[5h7g]], [[5h7h]] – hBcl-6 BTB domain + F1324 peptide<br />
	**[[1r2b]] – hBcl-6 BTB domain + SMRT peptide<br />		**[[1r2b]] – hBcl-6 BTB domain + SMRT peptide<br />
		+	**[[6tof]], [[6tog]], [[6toh]], [[6toi]], [[6toj]], [[6too]] – hBcl-6 BTB domain + peptide + pyridine derivative<br />
		+	**[[6tok]], [[6tol]], [[6tom]], [[6ton]] – hBcl-6 BTB domain + peptide + pyrimidine derivative<br />
	**[[2lce]] – hBcl-6 zinc fingers 2-3 residues 540-602 - NMR<br />		**[[2lce]] – hBcl-6 zinc fingers 2-3 residues 540-602 - NMR<br />
	**[[2yrm]], [[2eos]] – hBcl-6 zinc finger-C2H2 residues 515-544 - NMR<br />		**[[2yrm]], [[2eos]] – hBcl-6 zinc finger-C2H2 residues 515-544 - NMR<br />
Line 95:		Line 97:
	**[[6bze]] – hBcl-10 CARD domain – Cryo EM<br />		**[[6bze]] – hBcl-10 CARD domain – Cryo EM<br />
	**[[6gk2]] – hBcl-10 CARD domain + MALTI death domain – Cryo EM<br />		**[[6gk2]] – hBcl-10 CARD domain + MALTI death domain – Cryo EM<br />
		+
		+	*Bcl-11A
		+
		+	**[[6ki6]] – hBcl-11A + DNA<br />

	*Bcl-W (Bcl-2-like protein 2)		*Bcl-W (Bcl-2-like protein 2)

Michal Harel at 09:36, 15 June 2020

Michal Harel — Mon, 15 Jun 2020 09:36:25 GMT

←Older revision		Revision as of 09:36, 15 June 2020
Line 181:		Line 181:
	**[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br />		**[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant)<br />
	}}		}}
		+	[[Category:Topic Page]]

Michal Harel: New page: ==3D structures of B-cell lymphoma proteins== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *Bcl-xL (Bcl-2-like p...

Michal Harel — Tue, 02 Apr 2019 08:54:18 GMT

New page: ==3D structures of B-cell lymphoma proteins== Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} {{#tree:id=OrganizedByTopic|openlevels=0| *Bcl-xL (Bcl-2-like p...

New page

==3D structures of B-cell lymphoma proteins==

Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
{{#tree:id=OrganizedByTopic|openlevels=0|

*Bcl-xL (Bcl-2-like protein 1)

**[[1maz]], [[1r2d]], [[2b48]], [[4ppi]] – hBcl-xL – human 
**[[1r2e]], [[1r2g]], [[1r2h]], [[1r2i]], [[3cva]] - hBcl-xL (mutant) 
**[[2lpc]], [[2m03]], [[2me8]], [[2me9]], [[1lxl]] - hBcl-xL – NMR 
**[[6bf2]] - hBcl-xL (mutant) – NMR 
**[[3fdm]] - hBcl-xL + α/β peptide foldamer 
**[[2mej]] - hBcl-xL + p53 - NMR 
**[[3inq]] - hBcl-xL (mutant) + inhibitor 
**[[1ysg]], [[3sp7]], [[3spf]], [[3wiz]], [[4tuh]], [[3zln]], [[3zk6]], [[3zlo]], [[3zlr]], [[4c52]], [[4c5d]], [[2yxj]], [[4qnq]], [[4qvx]] - hBcl-xL + inhibitor 
**[[2w3l]] – hBcl-xL + quinoline derivative 
**[[2o1y]], [[2o2m]], [[2o2n]], [[1ysi]], [[1ysn]], [[2o21]], [[2o22]], [[2o2f]] - hBcl-xL + sulfonamide derivative – NMR 
**[[3qkd]], [[4ehr]] - hBcl-xL + sulfonamide derivative 
**[[2pon]] - hBcl-xL + Beclin-1 residues 1-23 - NMR 
**[[3ihc]], [[3iih]], [[1pq0]] – mBcl-xL residues 1-196 – mouse 
**[[3ihd]], [[3ihe]], [[3ihf]], [[3iig]], [[3ilb]], [[3ilc]] - mBcl-xL residues 1-196 (mutant) 
**[[2bzw]] - mBcl-xL residues 1-211 + BAD 
**[[1pq1]], [[5c3g]] - mBcl-xL residues 1-196 + BIM peptide 
**[[1af3]] - rBcl-xL soluble domain 
**[[1bxl]] - Bcl-xL + Bak peptide – Escherichia coli – NMR 
**[[5twa]] - Bcl-xL + Bak peptide – sponge 

*Bcl-xL complex with BH3 domain peptide

**[[3pl7]] - hBcl-xL (mutant) + apoptosis regulator BAX BH3 domain 
**[[5fmk]], [[5fmj]] - hBcl-xL + Bak BH3 domain 
**[[4qve]] - hBcl-xL + BID BH3 domain 
**[[1g5j]] - hBcl-xL + BAD BH3 peptide 
**[[5b1z]] - hBcl-xL + BHX BH3 domain 
**[[4z9v]] - hBcl-xL + TCTP BH3 domain 
**[[6dcn]] - hBcl-xL + Beclin-1 BH3 domain 
**[[2p1l]] - hBcl-xL (mutant) + Beclin-1 BH3 domain 
**[[2yq6]], [[4qvf]], [[4yk9]], [[3fdl]], [[5agx]], [[4yj4]], [[3io8]], [[2yq7]], [[5vx3]], [[5agw]] - hBcl-xL + BIM BH3 domain 
**[[2yj1]], [[4bpk]], [[4hnj]] - hBcl-xL + α/β-Puma BH3 domain 
**[[4a1u]], [[4a1w]] - hBcl-xL + α/β-foldamer BH3 domain 
**[[3r85]] - hBcl-xL + heme-binding protein BH3 peptide 
**[[2lp8]] – hBcl-xL + Bcl-2 homologous antagonist/killer BH3 peptide - NMR 
**[[2m04]] – hBcl-xL (mutant) + Bcl-2 binding component 3 BH3 peptide - NMR 
**[[5wos]] - Bcl-xL + hBIM BH3 domain – canarypox virus 
**[[5tzp]] - fpvBcl-xL + BIK BH3 domain – fowlpox virus 
**[[5tzq]] - fpvBcl-xL + Bmf BH3 domain 

*Bcl-2

**[[1gjh]], [[1g5m]] – hBcl-2 
**[[4aq3]], [[4man]], [[5jsn]], [[4ieh]] – hBcl-2 + inhibitor 
**[[4lvt]], [[4lxd]] – hBcl-2 (mutant) + inhibitor 
**[[5fcg]] – hBcl-2 (mutant) + HBX BH3 domain 
**[[2xa0]] – hBcl-2 residues 1-207 + apoptosis regulator Bax BH3 domain 
**[[2o21]], [[2o22]], [[2o2f]], [[1ysw]] - hBcl-2 + sulfonamide derivative – NMR

*Bcl-2-related protein A1 (Bfl-1)

**[[5whi]] - hBcl-2A1 (mutant) 
**[[2vm6]] – hBcl-2A1 + hBIM BH3 peptide 
**[[2vof]] - mBcl-2A1 + Bcl-2 binding component 3 BH3 peptide 
**[[2vog]] - mBcl-2A1 + Bmf BH3 peptide 
**[[2voh]] - mBcl-2A1 + Bak BH3 peptide 
**[[2voi]] - mBcl-2A1 + BID BH3 peptide 
**[[3mqp]] - hBcl-2A1 + Noxa BH3 peptide 
**[[5uul]] - hBcl-2A1 + PUMA BH3 peptide 
**[[5uuk]], [[5uup]] - hBcl-2A1 + Bfl-1 peptide 
**[[4zeq]] - hBcl-2A1 + BID BH3 peptide 

*Bcl-3

**[[1k1a]], [[1k1b]] – hBcl-3 ankyrin repeat domain 

*Bcl-6

**[[3e4u]], [[1r28]], [[1r29]], [[4u2m]] – hBcl-6 BTB domain 
**[[3lbz]], [[5mw6]], [[5mw2]], [[5mwd]], [[5n1x]], [[5n1z]], [[5n20]], [[5n21]], [[5x4m]], [[5x4n]], [[5x4o]], [[5x4p]], [[5x9o]], [[5x9p]], [[5x4o]], [[5x4q]], [[6ew8]], [[6ew7]], [[6ew6]], [[6c3n]] – hBcl-6 BTB domain + inhibitor 
**[[6cq1]], [[6c3l]] – hBcl-6 BTB domain (mutant) + inhibitor 
**[[4cp3]] – hBcl-6 BTB domain + antibiotic 
**[[3bim]] – hBcl-6 BTB domain (mutant) + Bcl-6 corepressor 
**[[5h7g]], [[5h7h]] – hBcl-6 BTB domain + F1324 peptide 
**[[1r2b]] – hBcl-6 BTB domain + SMRT peptide 
**[[2lce]] – hBcl-6 zinc fingers 2-3 residues 540-602 - NMR 
**[[2yrm]], [[2eos]] – hBcl-6 zinc finger-C2H2 residues 515-544 - NMR 
**[[2en2]] – hBcl-6 zinc finger-C2H2 residues 598-626 - NMR 

*Bcl-9

**[[3sl9]] – hBcl-9 residues 344-396 + catenin β-1 
**[[2gl7]] – hBcl-9 residues 344-396 + catenin β-1 + transcription factor 7-like 

*Bcl-10

**[[2mb9]] – hBcl-10 CARD domain (mutant) – NMR 
**[[6bze]] – hBcl-10 CARD domain – Cryo EM 
**[[6gk2]] – hBcl-10 CARD domain + MALTI death domain – Cryo EM 

*Bcl-W (Bcl-2-like protein 2)

**[[1o0l]], [[1mk3]], [[2y6w]] – hBcl-W (mutant) 
**[[1zy3]], [[4cim]] - hBcl-W (mutant) + BID BH3 peptide 
**[[4k5a]], [[4k5b]] - Bcl-W (mutant) + ankyrin repeat - bovine 
**[[4cin]] - hBcl-W + BH3 peptide 

*Bcl-2-like protein 4 (Bax)

**[[4bd7]], [[4s0o]], [[4s0p]] - hBax 
**[[4bd8]], [[5w60]], [[5w61]] – hBax (mutant) 
**[[2lr1]] - hBax + VMIA peptide 
**[[4bd6]] – hBax (mutant) + BH3 peptide 
**[[2k7w]] – hBax + BIM BH3 peptide - NMR 
**[[4zie]], [[4zif]], [[4zig]], [[4zih]], [[4zii]], [[5vww]] – hBax (mutant) + BIM BH3 peptide 
**[[4bd2]] – hBax (mutant) + BID BH3 peptide 
**[[5w5z]], [[5w5x]] – hBax (mutant) + antibody 

*Bcl-2-like protein 5

**[[3i1h]] - hBcl-2-L-5 + hBak 

*Bcl-2-like protein 7 (Bak, Bcl-2 homologous antagonist/killer)

**[[2yv6]], [[2imt]], [[2jcn]], [[2ims]] – hBak 
**[[5fmi]], [[4u2u]], [[5vx1]] – hBak (mutant) 
**[[4u2v]] – hBak/GFP 
**[[3qbr]] - hBak + sjA 
**[[2xpx]] - hBak fragment + BHRF1 
**[[5vwx]], [[5vwy]], [[5vwz]], [[5vx0]] - hBak + BIM BH3 domain 
**[[5vwv]] - hBak (mutant)+ BIM BH3 domain 
**[[2m5b]] - hBak + BID BH3 domain - NMR 

*Bcl-2-like protein 10

**[[2kua]] – mBcl-2-L-10 
**[[4b4s]] - hBcl-2-L-10 + hBIM BH3 peptide 

*Bcl-2-like protein 11 (BIM)

**[[2nl9]] – hBIM + Mcl-1 

*Mcl-1 (Bcl-2-like protein 3)

**[[1wsx]] – mMcl-1 residues 152-308 - NMR 
**[[6dm8]] - mMcl-1/MBP + inhibitor 
**[[3mk8]] - hMcl-1 residues 174-324 
**[[2mhs]] - hMcl-1 residues 174-324 (mutant) 
**[[4wms]] - hMcl-1/MBP (mutant) 
**[[5lof]] - hMcl-1/MBP + inhibitor 
**[[4wmx]], [[4wmw]], [[4wmv]] - hMcl-1/MBP + ligand 
**[[4wmu]], [[4wmt]] - hMcl-1/MBP (mutant) + ligand 
**[[4wgi]] - hMcl-1/MBP (mutant) + macrolactam 
**[[3wix]], [[3wiy]], [[4oq5]], [[4oq6]], [[4hw2]], [[4hw3]], [[4hw4]], [[4wmr]], [[4zbf]], [[4zbi]], [[5fc4]], [[5fdo]], [[5fdr]], [[5iez]], [[5if4]], [[5jsb]], [[5ku9]], [[5vkc]], [[6b4l]], [[6b4u]], [[6bw2]], [[6bw8]], [[6fs1]], [[6fs2]] - hMcl-1 residues 174-324 + inhibitor 
**[[5uum]] - hMcl-1 residues 174-324 + FS2 peptide 
**[[6mbd]] - hMcl-1 residues 174-324 + DM1 peptide 
**[[6mbe]] - hMcl-1 residues 174-324 + DM7 peptide 
**[[5c3f]] - hMcl-1 residues 174-324 + BIB MM 
**[[5mes]], [[5mev]], [[6fs0]] - hMcl-1 residues 153-221 + inhibitor + antibody 
**[[6fs0]] - hMcl-1 residues 174-324 + inhibitor + antibody 

*Mcl-1 complex with BH3 domain peptide

**[[2nla]], [[4g35]] – rMcl-1 fragment + NoxaB BH3 domain 
**[[2jm6]], [[2rod]] – mMcl-1 fragment + NoxaB fragment – NMR 
**[[2roc]] - mMcl-1 fragment + Puma BH3 domain 
**[[3kz0]] - hMcl-1 + MB7 BH3 domain 
**[[3pk1]] – hMcl-1 fragment + hBax BH3 domain 
**[[2kbw]] - hMcl-1 fragment + BID BH3 peptide – NMR 
**[[4bpj]], [[4bpi]] - hMcl-1 fragment + Puma BH3 peptide 
**[[5c6h]] - hMcl-1 fragment + Mule BH3 peptide 
**[[5w89]], [[5w8f]], [[3kj0]], [[3kj1]], [[3kj2]], [[3io9]], [[3d7v]], [[2pqk]], [[5vx2]] - hMcl-1 fragment + BIM BH3 peptide 
**[[2kbw]] - hMcl-1 fragment + BID BH3 peptide - NMR 

*M11

**[[2o42]], [[2jbx]] – MvM11L – Myxoma virus 
**[[2jby]] – MvM11L + Bcl-2 homologous antagonist/killer 
**[[3dvu]], [[3bl2]], [[4mi8]] – M11 + Beclin-1 – Murid herpesvirus 

*N1L

**[[2i39]] – VvN1L – Vaccinia virus 
**[[4bbb]], [[4bbc]], [[4bbd]] – VvN1L (mutant) 
}}